rs12350739 — BNC2 Regulatory variant

The Enhancer Switch That Determines How Much Melanin Your Skin Makes

BNC2 encodes basonuclin-2, a zinc finger transcription factor¹¹ zinc finger transcription factor
A protein that reads and controls gene activity using zinc-coordinated finger-shaped domains that is expressed in melanocytes and plays an essential role in supporting the survival and patterning of pigment-producing cells. Unlike the better-known pigmentation genes (MC1R, TYR, OCA2) that act directly within melanocytes, BNC2 operates partly through the extracellular environment in which melanocytes reside. The variant rs12350739 sits not inside BNC2 itself, but in a conserved intergenic enhancer approximately 130 kilobases upstream of the BNC2 gene body. This regulatory element acts as a dimmer switch: depending on which allele you carry, it controls how actively BNC2 is transcribed in melanocytes, which in turn modulates the saturation of skin pigmentation²² saturation of skin pigmentation
The richness or intensity of melanin color, distinct from overall hue — how deeply pigmented the skin appears, and how prone it is to freckling and age-related pigmented spots.

The Mechanism

The highly conserved region surrounding rs12350739 functions as an allele-dependent enhancer³³ allele-dependent enhancer
A DNA regulatory sequence whose activity differs between the two allele variants that regulates BNC2 transcription in human melanocytes. When you carry the G allele, the chromatin at this locus is accessible: the enhancer is active, BNC2 is expressed at higher levels, and melanin production is robustly supported. When you carry the A allele, the same region shows inaccessible chromatin — the enhancer is only weakly active, BNC2 expression falls, and the downstream support for melanocyte function is reduced. The consequence at the phenotypic level is lighter, less saturated skin pigmentation and a tendency toward patchier, uneven melanin distribution — the biological substrate for freckling⁴⁴ freckling
Small concentrated deposits of melanin in skin cells, more visible with low overall pigmentation and age spots.

This is a regulatory variant, not a protein-coding change: BNC2 protein structure is unaltered, but its abundance in melanocytes is tuned by which allele is present. The effect scales with allele dosage — AA homozygotes show the lowest BNC2 expression and lightest pigmentation, AG heterozygotes are intermediate, and GG homozygotes show the highest expression and darkest pigmentation contribution from this locus.

The Evidence

The key mechanistic study was Visser, Palstra & Kayser 2014⁵⁵ Visser, Palstra & Kayser 2014
Human skin color is influenced by an intergenic DNA polymorphism regulating transcription of the nearby BNC2 pigmentation gene. Human Molecular Genetics, 23(21):5750–5760, which demonstrated through chromatin accessibility assays and reporter experiments that rs12350739 is the functional causal variant underlying the original BNC2 GWAS signal at rs10756819. The paper showed that A-allele chromatin is inaccessible at this locus, while G-allele chromatin is open and enhancer-active in human melanocytes, and that the A allele predominates in European populations (~57%), is rare in sub-Saharan Africans (~1%), and is essentially absent in East Asians.

The original GWAS signal at the BNC2 locus was identified in a Dutch candidate gene cohort of 5,860 individuals⁶⁶ Dutch candidate gene cohort of 5,860 individuals
rs10756819 associated with skin color saturation, p<0.05 in all cohorts where BNC2 variants were significantly associated with the saturation dimension of quantified skin color. A subsequent GWAS of facial pigmented spots in 2,844 Dutch Europeans⁷⁷ GWAS of facial pigmented spots in 2,844 Dutch Europeans
rs62543565, P=2.3×10⁻⁸, replicated in 599 individuals confirmed BNC2 at genome-wide significance for age-related facial lentigines and freckling, independent of background skin color — suggesting the gene's influence on melanin distribution goes beyond overall pigmentation level.

The skin cancer connection comes from a large GWAS of cutaneous squamous cell carcinoma (SCC)⁸⁸ large GWAS of cutaneous squamous cell carcinoma (SCC)
7,404 cases and 292,076 controls of European ancestry, in which the correlated BNC2 variant rs10810657 reached genome-wide significance (P=1.4×10⁻⁸, OR=0.90 for the T allele), confirming that the G-allele / high-BNC2 / darker-pigmentation haplotype carries a protective effect against SCC. Conversely, A-allele carriers — those with lighter, less saturated skin and lower BNC2 expression — show mildly elevated SCC risk.

Practical Implications

The clinical relevance of rs12350739 is primarily photoprotective. Carriers of two A alleles (AA genotype) have constitutionally lighter and less saturated skin, a genetic tendency toward freckling and age-related pigmented spots, and a modestly elevated susceptibility to UV-induced skin damage including squamous cell carcinoma. These individuals benefit from more rigorous daily sun protection and systematic dermatology surveillance than their GG counterparts. The A allele's high frequency in Europeans (~57%) means this is a common, not rare, variant — the majority of Europeans carry at least one A allele.

Importantly, the photoprotective deficit from this variant can be largely offset with consistent behavioral strategies: daily broad-spectrum sunscreen reduces UV-induced DNA damage independently of constitutive melanin levels. Freckling tendency itself is not medically harmful but serves as a visible indicator of lighter pigmentation and greater UV sensitivity in childhood — individuals who freckled heavily in youth often have higher cumulative UV exposure reflected in adult skin aging patterns.

Interactions

rs12350739 is in strong linkage disequilibrium (r²=0.90) with rs10810657, the SCC GWAS lead SNP at the BNC2 locus, meaning these variants are nearly always inherited together in Europeans. The nearby rs62543565 is independently associated with facial pigmented spot density. The rs10756819 intronic variant (the original GWAS proxy hit for skin saturation) is also in LD with rs12350739.

For melanoma risk, the BNC2 locus interaction with MC1R (rs1805007, rs1805008) is relevant: low-BNC2 AA carriers who also carry MC1R loss-of-function variants face a compounded photoprotective deficit, with lighter and less uniformly pigmented skin that burns easily. Similarly, concurrent carriage of SLC45A2 L374 allele (rs16891982 GG) and AA at BNC2 may have additive effects on reduced melanin. These interactions are observationally consistent with pigmentation pathway biology but specific combined-genotype effect sizes from adequately powered studies are not yet published.

In zebrafish, loss of bnc2⁹⁹ loss of bnc2
bnc2 mutant fish showing melanophore death and pigment fragmentation causes melanocytes, xanthophores, and iridophores to die and be extruded from the skin — a dramatic demonstration that this gene's non-autonomous support role in the extracellular niche is critical for pigment cell viability. The mammalian analog of this function, operating more subtly through enhancer regulation, may explain why reduced BNC2 expression biases toward patchier, less stable melanin distribution patterns rather than simple global depigmentation.